TC BioPharm Holdings PLC (TCBP) Key Ratios
$0.49
$-0.01
(-2.04%)
As on 17-Apr-2025 09:30EDT
Market cap
$0 Mln
Revenue (TTM)
$-- Mln
P/E Ratio
--
P/B Ratio
0.1
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -- | -- | -- |
| EBIT | -- | 37.29 | -17.84 | -168.30 | -- |
| Net Profit | 0.00 | 36.54 | -349.68 | -2.82 | -- |
| EPS | 92.38 | 90.88 | 95.79 | 24.61 | -- |
| Book Value | -- | -- | -92.42 | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Dec-23 | Dec-22 | Dec-21 |
| EBIT-Margin
| -341.30 | -- | -- | -314.32 | -368.28 |
| Net Margin
| -- | -- | -- | -- | -- |
| Return on equity
| -79.68 | -- | -391.64 | 16.19 | 136.40 |
| Return on Capital
| 525.99 | -- | -162.55 | -125.63 | 1,866.13 |
| Return on Assets
| -83.20 | -- | -58.42 | -13.60 | -177.58 |
| Debt to Equity (x)
| -- | -- | 0.67 | 7.40 | -0.96 |
Profitability
ROCE
-162.55
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
TC BioPharm Holdings PLC (TCBP)
|
-162.55
|
-125.63
|
1,866.13
|
3,895.78
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-391.64
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
TC BioPharm Holdings PLC (TCBP)
|
-391.64
|
16.19
|
136.40
|
185.44
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
-58.42
--
Profit after tax / Average Total assets * 100
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
TC BioPharm Holdings PLC (TCBP)
|
-58.42
|
-13.60
|
-177.58
|
-62.71
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Margin
--
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
TC BioPharm Holdings PLC (TCBP)
|
--
|
-314.32
|
-368.28
|
-310.37
|
-193.78
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Margin
--
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
TC BioPharm Holdings PLC (TCBP)
|
--
|
-34.17
|
-686.12
|
-275.84
|
-177.07
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-1.00
--
Year on year growth in net sales
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
TC BioPharm Holdings PLC (TCBP)
|
-1.00
|
0.94
|
--
|
-0.42
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
-17.84
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
TC BioPharm Holdings PLC (TCBP)
|
-17.84
|
-65.83
|
-18.66
|
7.52
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
-349.68
--
Year on year growth in profit after tax
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
TC BioPharm Holdings PLC (TCBP)
|
-349.68
|
90.32
|
-148.74
|
10.05
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EPS Growth
0.96
--
Year on year growth in earnings per share
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
TC BioPharm Holdings PLC (TCBP)
|
0.96
|
0.97
|
-48.74
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.67
--
Total debt / Net worth
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
TC BioPharm Holdings PLC (TCBP)
|
0.67
|
7.40
|
-0.96
|
-0.77
|
-1.19
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.11
--
(Short term borrowings / Net worth)
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
TC BioPharm Holdings PLC (TCBP)
|
0.11
|
2.96
|
-0.46
|
-0.13
|
-0.16
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.20
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
TC BioPharm Holdings PLC (TCBP)
|
1.20
|
0.81
|
0.19
|
0.53
|
1.09
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Quick Ratio
1.46
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
TC BioPharm Holdings PLC (TCBP)
|
1.46
|
1.01
|
0.26
|
0.83
|
1.84
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Interest Coverage
-171.51
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
TC BioPharm Holdings PLC (TCBP)
|
-171.51
|
-1.79
|
-2.12
|
-21.03
|
-24.11
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
--
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
TC BioPharm Holdings PLC (TCBP)
|
--
|
46.91
|
74.69
|
62.58
|
3.14
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Asset Turnover
--
--
Sales / Average Total Assets
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
TC BioPharm Holdings PLC (TCBP)
|
--
|
0.40
|
0.26
|
0.23
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
TC BioPharm Holdings PLC (TCBP)
|
--
|
155.86
|
250.70
|
124.24
|
11.48
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
